Literature DB >> 20070589

Productive cough is an independent risk factor for the development of COPD in former smokers.

Takashi Yamane1, Noboru Hattori, Yoshihiro Kitahara, Yoshinori Haruta, Hideo Sasaki, Akihito Yokoyama, Nobuoki Kohno.   

Abstract

UNLABELLED: The presence of productive cough was an independent risk factor for the development of COPD in Japanese men, particularly former smokers. Stage 0 disease, as defined in GOLD 2001 guidelines, is relevant for the identification of subjects at risk of developing COPD. BACKGROUND AND
OBJECTIVE: It has yet to be determined whether the presence of productive cough is a risk factor for the development of COPD. The aim of the present study was to obtain more information on this potential association in Japanese men.
METHODS: Seven hundred and eighty-three men with normal spirometry who did not have respiratory disease were recruited. The subjects were divided into three groups: group A, non-smokers; group B, those with a positive smoking history without productive cough; and group C, those with a positive smoking history and productive cough. The incidence rates of COPD were compared among the three groups and the relative risks for the development of COPD were assessed.
RESULTS: During the mean follow-up period of 33.6+/-20.4 months, 19 (2.4%) subjects developed COPD. The incidence rate of COPD was significantly higher in group C than in group B (10.1 vs 2.2%, P=0.003). A multivariate analysis of data for all subjects, current smokers and former smokers revealed that productive cough was an independent risk factor for the development of COPD in all subjects and former smokers but not in current smokers.
CONCLUSIONS: Productive cough was an independent risk factor for the development of COPD in Japanese men. In particular, former smokers who complain of this symptom should be regarded as being at high risk for the development of COPD. The data suggested that stage 0 disease, as defined in the Global Initiative for Chronic Obstructive Lung Disease 2001 guidelines, is relevant for the identification of subjects at risk of developing COPD.

Entities:  

Mesh:

Year:  2010        PMID: 20070589     DOI: 10.1111/j.1440-1843.2009.01682.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  8 in total

1.  Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity.

Authors:  Ben-Gary Harvey; Yael Strulovici-Barel; Robert J Kaner; Abraham Sanders; Thomas L Vincent; Jason G Mezey; Ronald G Crystal
Journal:  Eur Respir J       Date:  2015-11-05       Impact factor: 16.671

Review 2.  Systematic review of the evidence relating FEV1 decline to giving up smoking.

Authors:  Peter N Lee; John S Fry
Journal:  BMC Med       Date:  2010-12-14       Impact factor: 8.775

3.  Differences in serum SP-D levels between German and Japanese subjects are associated with SFTPD gene polymorphisms.

Authors:  Yasushi Horimasu; Noboru Hattori; Nobuhisa Ishikawa; Sonosuke Tanaka; Francesco Bonella; Shinichiro Ohshimo; Josune Guzman; Ulrich Costabel; Nobuoki Kohno
Journal:  BMC Med Genet       Date:  2014-01-08       Impact factor: 2.103

Review 4.  Management of airway mucus hypersecretion in chronic airway inflammatory disease: Chinese expert consensus (English edition).

Authors:  Yongchun Shen; Shaoguang Huang; Jian Kang; Jiangtao Lin; Kefang Lai; Yongchang Sun; Wei Xiao; Lan Yang; Wanzhen Yao; Shaoxi Cai; Kewu Huang; Fuqiang Wen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-01-30

5.  Characteristics and related factors of bronchiectasis in chronic obstructive pulmonary disease.

Authors:  Qihong Yu; Haiying Peng; Bo Li; Hongyu Qian; Hong Zhang
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

6.  Association Between Non-obstructive Chronic Bronchitis and Incident Chronic Obstructive Pulmonary Disease and All-Cause Mortality: A Systematic Review and Meta-Analysis.

Authors:  Fan Wu; Huanhuan Fan; Jing Liu; Haiqing Li; Weifeng Zeng; Silan Zheng; Heshen Tian; Zhishan Deng; Youlan Zheng; Ningning Zhao; Guoping Hu; Yumin Zhou; Pixin Ran
Journal:  Front Med (Lausanne)       Date:  2022-01-25

7.  Pain problems for patients with mild and moderate chronic obstructive pulmonary disease - a community-based study in Shanghai.

Authors:  Tian Xiao; Xianfeng Zhou; Yun He; Yue Chen; Hua Qiu; Sheng Zhang; Xianglin Wei; Kang Wu; Xiaonan Ruan; Na Wang; Chaowei Fu
Journal:  J Pain Res       Date:  2017-09-15       Impact factor: 3.133

8.  Effects of Modified Zhisou Powder on Airway Mucus Production in Chronic Obstructive Pulmonary Disease Model Rats with Cold-Dryness Syndrome.

Authors:  Gao Zhen; Wang Jing; Jing Jing; Dan Xu; Li Zheng; Fengsen Li
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-18       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.